Sugi Predict

Sugi Predict / Compounds / SCHEMBL987813

SCHEMBL987813

SCHEMBL987813

COC(=O)c1cccc(C(=O)OC)c1Br

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.55
▸ CFTR P13569 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ KDM4E B2RXH2 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ SLC6A3 Q01959 3/20 0.53
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ KMT2A Q03164 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ MAPT P10636 2/20 0.48
▸ CA5A P35218 1/20 0.48
▸ ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28679016 0.92 TSHR (0.50) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL16960155 0.92 LMNA (0.50) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL14296805 0.92 LMNA (0.50) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL27468185 0.90 TSHR (0.48) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL29279663 0.90 TSHR (0.52) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL29928832 0.88 TSHR (0.50) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL1707841 0.88 TSHR (0.50) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL16960929 0.88 TSHR (0.50) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL29616326 0.88 LMNA (0.66) TSHRLMNAALDH1A1CFTRHSD17B10
SCHEMBL1180154 0.86 TSHR (0.48) TSHRLMNAALDH1A1CFTRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027031-A Carbonyl ring-closed arylamine fluorescent compound with narrow band emission, and preparation method and application thereof 广东工业大学 2024-05-14 — — CN claimed
CN-110343084-B Double-condensed ring naphthopyran photochromic compound and preparation method thereof 天津孚信阳光科技有限公司 2022-12-02 — — CN claimed
CN-110343084-A Double condensed ring photochromic compound of naphtho-pyrans and preparation method thereof 天津孚信阳光科技有限公司 2019-10-18 — — CN claimed
US-12421251-B2 Cystic fibrosis transmembrane conductance regulator modulating agents VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-09-23 — — US disclosed
CN-113939288-B Modulators of MAS-related G protein receptor X4 and related products and methods 伊赛恩特制药公司 2025-04-25 — — CN disclosed
WO-2025045826-A1 COMPOUNDS FOR ACTIVATION OF FGFR1 SIGNALING THE CULTIVATED B. GMBH (DE) 2025-03-06 — — WO disclosed
CN-118772175-A Fused ring compound and application thereof 华南理工大学 2024-10-15 — — CN disclosed
CN-113905785-B Cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2024-07-19 — — CN disclosed
CN-118027031-A Carbonyl ring-closed arylamine fluorescent compound with narrow band emission, and preparation method and application thereof 广东工业大学 2024-05-14 — — CN disclosed
EP-4335498-A1 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATING AGENTS Vertex Pharmaceuticals Incorporated (US) 2024-03-13 — — EP disclosed
US-11840521-B2 Modulators of Mas-related G-protein receptor X4 and related products and methods ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-12 — — US disclosed
US-20110207701-A1 BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS ANACOR PHARMACEUTICALS, INC. (US) 2011-08-25 — — US disclosed
EP-2340290-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES Merck Patent GmbH (DE) 2011-07-06 — — EP disclosed
CN-102076814-A Novel materials for organic electroluminescence devices MERCK PATENT GMBH 2011-05-25 — — CN disclosed
US-20110112275-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-05-12 — — US disclosed
US-20110112275-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-05-12 — — US disclosed
US-20110112275-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-05-12 — — US disclosed
WO-2011022337-A1 BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS ANACOR PHARMACEUTICALS, INC. (US) 2011-02-24 — — WO disclosed
WO-2011006568-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-01-20 — — WO disclosed
WO-2010049050-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2010-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11840521-B2 Modulators of Mas-related G-protein receptor X4 and related products and methods MRGPRX4, MRGPRX1, MRGPRX2 TSHR 98/4885LMNA 3209/4885ALDH1A1 4266/4885
US-20110207701-A1 BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS BTD, BAD, BRI3BP TSHR 4354/4885LMNA 2086/4885ALDH1A1 4684/4885
US-20110112275-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES LAGE3, EML4, MCM4 TSHR 4848/4885LMNA 3294/4885ALDH1A1 347/4885
US-12421251-B2 Cystic fibrosis transmembrane conductance regulator modulating agents CFTR, SCNN1G, CLCN2 TSHR 947/4885LMNA 4621/4885ALDH1A1 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.